Growth Metrics

Phibro Animal Health (PAHC) Free Cash Flow (2016 - 2026)

Phibro Animal Health has reported Free Cash Flow over the past 13 years, most recently at $8.3 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 273.94% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $47.3 million, down 12.75%, while the annual FY2025 figure was $41.8 million, 50.92% down from the prior year.
  • Free Cash Flow for Q4 2025 was $8.3 million at Phibro Animal Health, up from -$4.5 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $58.4 million in Q2 2023 and troughed at -$33.9 million in Q3 2022.
  • A 5-year average of $8.8 million and a median of $5.6 million in 2024 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 833.68% in 2022 and later surged 2011.39% in 2025.
  • Year by year, Free Cash Flow stood at $12.4 million in 2021, then crashed by 199.0% to -$12.3 million in 2022, then soared by 267.36% to $20.6 million in 2023, then plummeted by 123.04% to -$4.7 million in 2024, then skyrocketed by 273.94% to $8.3 million in 2025.
  • Business Quant data shows Free Cash Flow for PAHC at $8.3 million in Q4 2025, -$4.5 million in Q3 2025, and $8.1 million in Q2 2025.